Clinical study of combination therapy of adoptive immunotherapy with proton therapy for pancreatic cancer
Not Applicable
- Conditions
- pancreatic cancer
- Registration Number
- JPRN-UMIN000012201
- Lead Sponsor
- Hyogo Ion Beam Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
Not provided
Exclusion Criteria
(1)Interstitial pneumonia (2)Active autoimmune disease (3)Active heart trouble (4)uncontrolable infectious diseases. (5)Serious drug allergy (6)Continuous systemic administration of steroids (7)Pregnancy (8)Positive for HIV or HTLV-1 (9)patients who are inadequate to enter this study due to the other reasons by physician's judgments
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method distant disease-free rate
- Secondary Outcome Measures
Name Time Method overall survival survival rate local control rate frequency and type of adverse events QOL immunological parameters